Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Change in Cash (2016 - 2025)

Traws Pharma (TRAW) has disclosed Change in Cash for 14 consecutive years, with -$6.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Cash rose 41.96% to -$6.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.0 million, a 105.09% increase, with the full-year FY2024 number at $517000.0, up 102.88% from a year prior.
  • Change in Cash was -$6.7 million for Q3 2025 at Traws Pharma, down from -$2.9 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $29.0 million in Q1 2021 to a low of -$11.5 million in Q3 2024.
  • A 5-year average of -$663421.1 and a median of -$4.3 million in 2022 define the central range for Change in Cash.
  • Peak YoY movement for Change in Cash: surged 617.13% in 2021, then tumbled 675.81% in 2025.
  • Traws Pharma's Change in Cash stood at -$4.3 million in 2021, then rose by 10.49% to -$3.9 million in 2022, then fell by 14.7% to -$4.4 million in 2023, then soared by 460.12% to $15.9 million in 2024, then crashed by 141.82% to -$6.7 million in 2025.
  • Per Business Quant, the three most recent readings for TRAW's Change in Cash are -$6.7 million (Q3 2025), -$2.9 million (Q2 2025), and -$5.4 million (Q1 2025).